Cargando…

Consumption of cranberry as adjuvant therapy for urinary tract infections in susceptible populations: A systematic review and meta-analysis with trial sequential analysis

The efficacy of cranberry (Vaccinium spp.) as adjuvant therapy in preventing urinary tract infections (UTIs) remains controversial. This study aims to update and determine cranberry effects as adjuvant therapy on the recurrence rate of UTIs in susceptible groups. According to PRISMA guidelines, we c...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Jia-yue, Yang, Chao, Xu, Deng-feng, Xia, Hui, Yang, Li-gang, Sun, Gui-ju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8412316/
https://www.ncbi.nlm.nih.gov/pubmed/34473789
http://dx.doi.org/10.1371/journal.pone.0256992
_version_ 1783747427615899648
author Xia, Jia-yue
Yang, Chao
Xu, Deng-feng
Xia, Hui
Yang, Li-gang
Sun, Gui-ju
author_facet Xia, Jia-yue
Yang, Chao
Xu, Deng-feng
Xia, Hui
Yang, Li-gang
Sun, Gui-ju
author_sort Xia, Jia-yue
collection PubMed
description The efficacy of cranberry (Vaccinium spp.) as adjuvant therapy in preventing urinary tract infections (UTIs) remains controversial. This study aims to update and determine cranberry effects as adjuvant therapy on the recurrence rate of UTIs in susceptible groups. According to PRISMA guidelines, we conducted a literature search in Web of Science, PubMed, Embase, Scopus, and the Cochrane Library from their inception dates to June 2021. We included articles with data on the incidence of UTIs in susceptible populations using cranberry-containing products. We then conducted a trial sequential analysis to control the risk of type I and type II errors. This meta-analysis included 23 trials with 3979 participants. We found that cranberry-based products intake can significantly reduce the incidence of UTIs in susceptible populations (risk ratio (RR) = 0.70; 95% confidence interval(CI): 0.59 ~ 0.83; P<0.01). We identified a relative risk reduction of 32%, 45% and 51% in women with recurrent UTIs (RR = 0.68; 95% CI: 0.56 ~ 0.81), children (RR = 0.55; 95% CI: 0.31 ~ 0.97) and patients using indwelling catheters (RR = 0.49; 95% CI: 0.33 ~ 0.73). Meanwhile, a relative risk reduction of 35% in people who use cranberry juice compared with those who use cranberry capsule or tablet was observed in the subgroup analysis (RR = 0.65; 95% CI: 0.54 ~ 0.77). The TSA result for the effects of cranberry intake and the decreased risk of UTIs in susceptible groups indicated that the effects were conclusive. In conclusion, our meta-analysis demonstrates that cranberry supplementation significantly reduced the risk of developing UTIs in susceptible populations. Cranberry can be considered as adjuvant therapy for preventing UTIs in susceptible populations. However, given the limitations of the included studies in this meta-analysis, the conclusion should be interpreted with caution.
format Online
Article
Text
id pubmed-8412316
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-84123162021-09-03 Consumption of cranberry as adjuvant therapy for urinary tract infections in susceptible populations: A systematic review and meta-analysis with trial sequential analysis Xia, Jia-yue Yang, Chao Xu, Deng-feng Xia, Hui Yang, Li-gang Sun, Gui-ju PLoS One Research Article The efficacy of cranberry (Vaccinium spp.) as adjuvant therapy in preventing urinary tract infections (UTIs) remains controversial. This study aims to update and determine cranberry effects as adjuvant therapy on the recurrence rate of UTIs in susceptible groups. According to PRISMA guidelines, we conducted a literature search in Web of Science, PubMed, Embase, Scopus, and the Cochrane Library from their inception dates to June 2021. We included articles with data on the incidence of UTIs in susceptible populations using cranberry-containing products. We then conducted a trial sequential analysis to control the risk of type I and type II errors. This meta-analysis included 23 trials with 3979 participants. We found that cranberry-based products intake can significantly reduce the incidence of UTIs in susceptible populations (risk ratio (RR) = 0.70; 95% confidence interval(CI): 0.59 ~ 0.83; P<0.01). We identified a relative risk reduction of 32%, 45% and 51% in women with recurrent UTIs (RR = 0.68; 95% CI: 0.56 ~ 0.81), children (RR = 0.55; 95% CI: 0.31 ~ 0.97) and patients using indwelling catheters (RR = 0.49; 95% CI: 0.33 ~ 0.73). Meanwhile, a relative risk reduction of 35% in people who use cranberry juice compared with those who use cranberry capsule or tablet was observed in the subgroup analysis (RR = 0.65; 95% CI: 0.54 ~ 0.77). The TSA result for the effects of cranberry intake and the decreased risk of UTIs in susceptible groups indicated that the effects were conclusive. In conclusion, our meta-analysis demonstrates that cranberry supplementation significantly reduced the risk of developing UTIs in susceptible populations. Cranberry can be considered as adjuvant therapy for preventing UTIs in susceptible populations. However, given the limitations of the included studies in this meta-analysis, the conclusion should be interpreted with caution. Public Library of Science 2021-09-02 /pmc/articles/PMC8412316/ /pubmed/34473789 http://dx.doi.org/10.1371/journal.pone.0256992 Text en © 2021 Xia et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Xia, Jia-yue
Yang, Chao
Xu, Deng-feng
Xia, Hui
Yang, Li-gang
Sun, Gui-ju
Consumption of cranberry as adjuvant therapy for urinary tract infections in susceptible populations: A systematic review and meta-analysis with trial sequential analysis
title Consumption of cranberry as adjuvant therapy for urinary tract infections in susceptible populations: A systematic review and meta-analysis with trial sequential analysis
title_full Consumption of cranberry as adjuvant therapy for urinary tract infections in susceptible populations: A systematic review and meta-analysis with trial sequential analysis
title_fullStr Consumption of cranberry as adjuvant therapy for urinary tract infections in susceptible populations: A systematic review and meta-analysis with trial sequential analysis
title_full_unstemmed Consumption of cranberry as adjuvant therapy for urinary tract infections in susceptible populations: A systematic review and meta-analysis with trial sequential analysis
title_short Consumption of cranberry as adjuvant therapy for urinary tract infections in susceptible populations: A systematic review and meta-analysis with trial sequential analysis
title_sort consumption of cranberry as adjuvant therapy for urinary tract infections in susceptible populations: a systematic review and meta-analysis with trial sequential analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8412316/
https://www.ncbi.nlm.nih.gov/pubmed/34473789
http://dx.doi.org/10.1371/journal.pone.0256992
work_keys_str_mv AT xiajiayue consumptionofcranberryasadjuvanttherapyforurinarytractinfectionsinsusceptiblepopulationsasystematicreviewandmetaanalysiswithtrialsequentialanalysis
AT yangchao consumptionofcranberryasadjuvanttherapyforurinarytractinfectionsinsusceptiblepopulationsasystematicreviewandmetaanalysiswithtrialsequentialanalysis
AT xudengfeng consumptionofcranberryasadjuvanttherapyforurinarytractinfectionsinsusceptiblepopulationsasystematicreviewandmetaanalysiswithtrialsequentialanalysis
AT xiahui consumptionofcranberryasadjuvanttherapyforurinarytractinfectionsinsusceptiblepopulationsasystematicreviewandmetaanalysiswithtrialsequentialanalysis
AT yangligang consumptionofcranberryasadjuvanttherapyforurinarytractinfectionsinsusceptiblepopulationsasystematicreviewandmetaanalysiswithtrialsequentialanalysis
AT sunguiju consumptionofcranberryasadjuvanttherapyforurinarytractinfectionsinsusceptiblepopulationsasystematicreviewandmetaanalysiswithtrialsequentialanalysis